Veterans United Foundation surprised our teammates at the Community Foundation for the CSRA on Friday with a HUGE check! Literally! Shell Berry, President/CEO of the CFCSRA, on behalf of Press on Fund, accepted a $10,000 donation from the Veterans United Foundation. Employees of Veterans United Home Loans donate a percentage of their salary to a fund held by […]
Continue reading >>The Research to Accelerate Cures and Equity (RACE) for Children Act would close a key loophole that currently allows potentially life-saving drugs to be tested for adults but not for children. “If the Senate passes this act, necessary studies will be conducted to provide physicians with more information for treating children with cancer. This wouldn’t be the […]
Continue reading >>For kids who survive, fighting cancer is only part of the battle. Current treatments leave lifelong side effects. Don’t our children deserve better?
Continue reading >>Press On is proud to welcome Dr. William E. Evans to our Medical Advisory Board. Dr. Evans served at St. Jude’s director and CEO from 2004-2014. From 1986 to 2002, he chaired the St. Jude Department of Pharmaceutical Sciences, and from 2002 to 2004 served as the hospital’s scientific director and executive vice president. He also […]
Continue reading >>By now, all of you have heard us use the words Play It Forward. Many of you participated in our social media challenge, and some of you even created your own fundraisers. Take Eric Neevel, an Avett Brothers fan who approached the Crawfords in July hoping to raise money in honor of Hallie. His idea […]
Continue reading >>Last week, I met with Bobby Houck and Hank Futch of the Blue Dogs along with Barbara Rivers of MUSC and Dr. Jackie Kraveka to discuss Dr. Kreveka’s breakthrough neuroblastoma research at MUSC. Through the Blue Dogs and Friends concert this December 28, all monies directed to Press On will be reserved for the support of this […]
Continue reading >>Below is a list of vendors with items that support Press On. We will update it as more items become available. CauseNetwork: Online Shopping at Over 1000 Stores! When you shop through our personal CauseNetwork Press On Marketplace a percentage of your purchases at hundreds of online stores will go to Press On. Special deals on hotels, as […]
Continue reading >>You’ve met the Chances and the Simkins, and now Press On is proud to announce that we are adding another family to the team: The Crawfords! Bob and Melanie Crawford’s daughter Hallie was diagnosed with a brain tumor in 2011; the Crawfords and Simkins met while at St. Jude Children’s Research Hospital. You may know Bob as […]
Continue reading >>Press On Tournament Weekend is September 16 & 17, 2016! Become a Partner! To sponsor, contact Hunter Baggs: hunter@baggsinsurance.com Totally, the most significant factor that is mature while purchasing medicaments from the Web is to make a best choice. To purchase medicaments online from a privileged web-site is safe. Other medicaments are used to treat […]
Continue reading >>Did you ever see the GoPro for a Cause video for Turner’s song “Possibilities,” recorded by Darius Rucker for St. Jude? Thanks GoPro, Darius Rucker, and St. Jude! Find the song on iTunes today!
Continue reading >>Yesterday I had the pleasure of spending the day at the Georgia Cancer Center at Augusta University, touring the research labs and clinical trials units, and listening to updates from Drs. Ted Johnson and David Munn regarding the Phase I relapsed brain tumor immunotherapy trial using the drug indoximod, the arms of this trial, and […]
Continue reading >>Augusta, GA. Research premised in altering the human T-Cell to attack cancer cells in much the same way that they would attack a virus or bacteria is showing much promise, as recently published in a New York Times article. The Press On Fund has invested in two separate studies for NK Cell therapy, for […]
Continue reading >>https://vimeo.com/138245192 AUGUSTA, Ga. – Press On, a donor-advised fund of The Community Foundation for the CSRA that is pushing for a cure for childhood cancer, is giving $2.5 million to fund translational pediatric cancer research and cutting-edge treatment alternatives at the Georgia Cancer Center. The announcement took place during a news conference Thursday at the GRU […]
Continue reading >>Press On is pleased to announce its long term partnership with Georgia Regents University in establishing a translational pediatric oncology research program for the State of Georgia. The landmark grant which made possible through was achieved with the valuable support of Janus Research and Tony and Jeanie Loop. For more information about this announcement, on […]
Continue reading >>Press On is pleased to announce the formation of a Medical Advisory Board. The Press On Medical Advisory Board (MAB) is comprised of leading experts in their fields. The MAB’s role is to advise the Press On Board on a range of issues and to provide scientific review of research proposals to ensure that the research programs […]
Continue reading >>Atlanta, GA: The Press On Fund and the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) are pleased to announce their first collaborative grant in the amount of $800,000 to Children’s Hospital of Los Angeles (CHLA), Children’s Healthcare of Atlanta (CHOA), and the University of Southern California, to initiate the New Approaches to Neuroblastoma […]
Continue reading >>Did you know only 4% of federal funding for cancer goes to childhood cancer research, despite the fact that childhood cancer kills more American children than any other disease? About 60% of all funding for the development of new drugs for adult cancer comes from pharmaceutical companies, but those companies provide almost no funding for […]
Continue reading >>Dear Press On supporters, we look forward to updating you periodically about progress being made as a result of Press On grants. We are very grateful for your belief in our cause and your trust that we will use your money wisely. This edition will focus on exciting developments at St. Jude Children’s Research Hospital in the fight against neuroblastoma. One of Press On’s primary goals is taking the laboratory discoveries enabled by Press On support and applying those discoveries in the clinic through clinical trials. Remarkably, Dr. Wing Leung and his talented support staff have opened three clinical trials as a result of Press On funding! If that weren’t exciting enough, Dr. Leung has also published an article in the peer-reviewed journal Blood that specifically credits Press On!
Continue reading >>On the first anniversary of Patrick’s death, January 9, 2013, we celebrated his life by dedicating a state of the art MIBG facility at Children’s Healthcare of Atlanta. Patrick travelled to Philadelphia and New York frequently for treatment not available in Atlanta, including four MIBG treatments at Children’s Hospital of Philadelphia. The first two were intended to be curative; the latter two merely palliative. All four were necessary as we fought for his life. As a reminder, MIBG is a radioactive tracer delivered intravenously that is absorbed by neuroblastoma cells. It is used at low doses to measure a neuroblastoma patient’s tumor burden. At high doses the radiation kills neuroblastoma cells while sparing nearby cells. As MIBG veterans, we recognized that MIBG treatment, either alone or in combination with other agents, was here to stay as part of neuroblastoma treatment. But there was no MIBG center located in the southeast during our battle. We at Press On changed that by funding the construction of the MIBG suite at CHOA, which uniquely includes two separate rooms – one for the patients and one for the family, as well as cutting edge technology designed to better entertain the kids and the parents during the four day isolation period. Importantly, the design also promised to reduce radiation exposure to the caregivers – both patents and clinicians.
Continue reading >>We have some exciting news to share with you regarding Press On and its move to the CSRA Community Foundation in Augusta, GA (“CSRACF”). As you know, Press On was the first “named fund” of CURE Childhood Cancer, Inc. For over six years, CURE’s administrative support, specifically efforts by Kristin Connor, her staff, the Board, […]
Continue reading >>
